DSM provides Q1 2023 trading update
02 May 2023
Prioritising profitability over sales volumes has supported our margins, which improved sequentially into the first quarter.”
DSM at a glance
Overview of our business & performance
A broad, global health and nutrition business
DSM is a global purpose-led, science-based company founded in 1902 and listed on Euronext Amsterdam. We are a leader in health, nutrition and bioscience which, through our products and solutions, aims to address some of the world’s biggest challenges whilst creating profitable growth in order to simultaneously deliver economic, environmental and societal value for all.
2022 key data
Group
€8,390m
Net sales
€7,269 in 2021
€1,395m
Adjusted EBITDA
€1,379 in 2021
16.6%
Adjusted EBITDA margin
19.0% in 2021
Health, Nutrition & Bioscience
€8,319m
Net sales
€7,166 in 2021
€1,490m
Adjusted EBITDA
€1,467 in 2021
17.9%
Adjusted EBITDA margin
20.5% in 2021
People
0.28
Frequency Index of Recordable Injuries
0.22 in 2021
77%
Employee Engagement Index
77% in 2021
26%
Female executives
23% in 2021
Planet
35%
Absolute reduction
Scope 1 + 2 GHG emissions (2016 baseline)
~26%
Structural improvement
Scope 1 + 2 GHG emissions (2016 baseline)
17%
Intensity improvement
Scope 3 GHG emissions (2016 baseline)
Profit
↑1%
Adjusted EBITDA
continuing operations vs. 2021
€310m
Adjusted net operating free cash flow
€555m
Net profit from continuing operations
Latest financial & regulatory news
-
-
DSM - delivery of shares
28 Apr 2023
Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules.
-
DSM - delivery of shares
26 Apr 2023
Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules.
Managing Board
Geraldine Matchett, Co-CEO
Geraldine Matchett is Co-Chief Executive Officer, Chief Financial Officer and Member of the Managing Board. She was appointed as Co-CEO on 15 February 2020 and joined DSM’s Managing Board in 2014.
Dimitri de Vreeze, Co-CEO
Dimitri de Vreeze is Co-Chief Executive Officer, Chief Operating Officer and Member of the Managing Board. He was appointed as Co-CEO on 15 February 2020 and joined DSM’s Managing Board in 2013.
Read more
-
Factbooks
DSM's Factbook provides investors and analysts with an introduction to the company and our key individual businesses.
-
-
Share performance
DSM's share performance in real time and historically.